The Onco'Zine Brief-logo

The Onco'Zine Brief

News & Politics Podcasts >

More Information

Location:

United States

Twitter:

@oncozine

Language:

English

Contact:

480 626 7218


Episodes

Improving Treatment for Patients with Pancreatic Cancer

7/6/2018
More
In this Edition of the OncoZine Brief, recorded during the Annual meeting of American Society of Clinical Oncology (ASCO), which took place June 1-5, 2018 in Chicago Illinois, Peter Hofland and Sonia Portillo interview Dr. Sotirios Stergiopoulos, who is the Chief Medical Officer of Ipsen, a global specialty-driven biopharmaceutical group focused on innovation and specialty care. The group develops and commercializes innovative medicines in three key therapeutic areas – Oncology,...

Duration:00:39:38

Advancing Treatment for Patients with Advanced Triple Negative Breast Cancer

6/29/2018
More
In this edition of The Onco’Zine Brief, recorded during the Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, Illinois, June 1 - 5, 2018, Peter Hofland and Sonia Portillo talk with Michael Pehl, President and Chief Executive Officer of Immunomedics, a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC). At this year’s ASCO meeting, nearly 40,000 attendees gathered to discuss the growing body of data on advanced, difficult to...

Duration:00:40:52

Results from ASCO 2018: Expanding the Reach of Precision Medicine (Part 1)

6/27/2018
More
This week in The Onco’Zine Brief Peter Hofland and Sonia Portillo talk with experts in oncology about some of the results presented during the annual meeting for the American Society of Clinical Oncology, held in Chicago, Ill, June 1 - 5, 2018. The theme of this year’s ASCO conference is: Delivering Discoveries: Expanding the Reach of Precision Medicine. More than 40,000 people attended the meeting. Hofland and Portillo interview Robert Dreicer, MD, MS, MACP, FASCO, the Associate Director...

Duration:00:40:16

Improving the Clinical Outcomes of Patients with Gastrointestinal Illness

6/27/2018
More
In this Edition of the Onco'Zine Brief, Peter Hofland and Sonia Portillo talk with Dr. John B. Kisiel, Assistant Professor of Medicine and a Consultant in the, Division of Gastroenterology and Hepatology, Department of Internal Medicine at the Mayo Clinic in Rochester, Minnesota. The overall goal of Dr. Kisiel is to improve the clinical outcomes of patients with gastrointestinal illness by providing excellent bedside care and conducting clinical and translational research. His primary...

Duration:00:40:53

Neil Canavan: How Scientists Unleash the Immune System to Kill Cancer

6/27/2018
More
In this edition of The Onco’Zine Brief, Sonia Portillo talks with Neil Canavan about the people involved in developing novel, advanced – and sometimes – highly personalized - anti-cancer treatments. Canavan is a veteran journalist with more than 20 years of experience reporting on science and medicine. For the last 5 years he has reported exclusively on issues related to drug development in cancer. In his new book "A Cure Within - Scientists Unleashing The Immune System to Kill Cancer,"...

Duration:00:41:45

Delivering Discoveries and Expanding the Reach of Precision Medicine: A Preview ASCO 2018

6/27/2018
More
In the edition of The Onco’Zine Brief Peter Hofland and Sonia Portillo review some of the most exciting and important study to be presented at the upcoming annual meeting of the American Society of Clinical Oncology (ASCO), to be held in Chicago, June 1 - 5, 2018. The theme of this year’s conference is: Delivering Discoveries: Expanding the Reach of Precision Medicine. More than 2,500 abstracts were accepted for presentation while an additional 3,350 abstracts were accepted for online...

Duration:00:42:00

A Distinguished Public Service Award for Exceptional Leadership in Cancer Advocacy Interview

5/27/2018
More
In this episode of the Onco’Zine Brief, Peter Hofland, Ph.D and Sonia Portillo talk with Col. James E. Williams who, during the annual meeting of the American Association for Cancer Research (AACR), held April 14 - 18, 2018 in Chicago, Ill, received the organization's Distinguished Public Service Award for Exceptional Leadership in Cancer Advocacy. Each year, the American Association for Cancer Research presents Special Recognition Awards to four individuals whose work made extraordinary...

Duration:00:40:45

Transforming Cancer to a Treatable Disease: An Interview with Dr. Elizabeth M. Jaffee

5/19/2018
More
In this edition of The Onco’Zine Brief Peter Hofland and Sonia Portillo are talking with Elizabeth M. Jaffee, MD, the 2018 - 2019 president of the American Association​ for Cancer Research (AACR). Dr. Jaffee’s, who's research is focused on the development of immune based therapies for pancreatic and breast cancers, is the deputy director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore. She is also the leader of the Stand Up To Cancer (SU2C)-Lustgarten...

Duration:00:37:42

Dr. Otis Brawley: Meeting the Challeng of Attacking Cancer from Every Angle

5/16/2018
More
This week in The Onco’Zine Brief: Peter Hofland, Ph.D and Sonia Portillo talk with Otis Brawley, MD, MACP the Chief Medical and Scientific Officer of the American Cancer Society. Hofland and Portillo ask Dr. Brawley about the past, present, and future of the fight against cancer, including screening, diagnostics and treatment with novel, targeted drugs, and the role of the American Cancer Society in helping to prevent cancer. In today’s interview they further address some of the most...

Duration:00:40:24

Addressing Key Challenges in Cancer Diagnostics and Treatment: Cancer Health Disparities

5/16/2018
More
Today in The Onco’Zine Brief Peter Hofland and Sonia Portillo talk with Dr. Michael Caligiuri., MD The Interview was recorded during the 2018 annual meeting of American Association​ for Cancer Research (AACR) held April 14-18th, 2018 in Chicago, Illinois. Michael A. Caligiuri is a renowned physician-scientist known for his work in immunology that is focused on human natural killer cells and their modulation for the treatment of leukemia, myeloma, and glioblastoma. To date over 1,500 cancer...

Duration:00:39:03

The Importance of Oral Care – and the Link with Cancer and Cancer Treatment

5/16/2018
More
Today in the OncoZine Brief, Peter Hofland, Ph.D and Sonia Portillo talk with Jim Ratcliff, CEO of Chairman of Rowpar Pharmaceuticals, the developer, manufacturer and marketer of best-in-class oral care products, sold under the CloSYS brand in Australia and the United States and under private label in Europe and India. In their interview with Dr.Ratcliff, Hofland and Portillo ask about the importance of oral care – and the link with cancer. Patients receiving treatment for cancer can...

Duration:00:41:08

Manon Rinsma: 13 Diamonds – Life Before Death from a Child’s Perspective

5/15/2018
More
The Netherlands-born writer Manon Rinsma is the author of a new book called “13 Diamonds – Life before death from a Child’s Perspective. In her book, Rinsma writes about losing her mother at a very young age - something so traumatic that it completely changed how she viewed the world. Rinsma's mother died of a form of brain cancer. For her remaining family - finding an answer to the question "how do you help a child when a family member has cancer," was not only difficult, it was also one...

Duration:00:36:28

Early Detection of Solid Tumor Based Cancers

5/15/2018
More
In this Edition of the OncoZine Brief, Peter Hofland, Ph.D and Sonia Portillo talk with Amit Kumar, Ph.D, Chairman, President & Chief Executive Officer of ITUS Corporation Executive Chairman of Anixa Diagnostics Corporation Dr. Kumar, is the inventor of the company’s Cchek™ technology for the early detection of tumor-based cancers and has been an investor, founder, director and CEO of several technology enterprises, both public and private. In today’s program Hofland and Portillo talk with...

Duration:00:41:50

Improving Targeted Therapies for Patients with Previously Untreated Advanced Classic Hodgkin Lymphoma

4/8/2018
More
In this episode of The Onco'Zine Brief, Peter Hofland, Ph.D and Sonia Portillo talk with Dr. Joseph M. Connors, MD., FRCPC, Clinical Professor in the Department of Medicine, Division of Medical Oncology, at the University of British Columbia and the chair of the Lymphoma Tumor Group for the British Columbia Cancer Agency. Dr. Connors is also the lead investigator of the ECHELON-1 clinical trial, a trial focusing on a new treatment option for Hodgekin Lymphoma. In this interview Hofland and...

Duration:00:40:14

Computational Oncology and Tumor Modeling - The Next Phase in Personalized Therapies for Cancer Patients

3/25/2018
More
In this episode of The OncoZine Brief, Peter Hofland, Ph.D and Sonia Portillo talk with Thomas Yankeelov, Ph.D, a computational biomedical engineer who came to The University of Texas at Austin from Vanderbilt University, where he served as the Ingram Professor of Cancer Research; professor of radiology and radiological sciences, physics, biomedical engineering and cancer biology; and director of cancer imaging research. He also served as a co-leader of the Host-Tumor Interactions Research...

Duration:00:41:01

The Development of Probody Therapeutics for the Targeting of Cancer

3/25/2018
More
In this edition of The OncoZine Brief, Peter Hofland, Ph.D and Sonia Portillo talk Sean McCarthy, D.Phil, President and Chief Executive Officer of CytomX, a biotechnology company developing a novel 'Probody Platform' which allows them to design therapeutic drugs that selectively activate in the tumor microenvironment while reducing drug activity in healthy tissue and in circulation. In addition to his work for CytomX, McCarthy is the author on multiple peer-reviewed scientific...

Duration:00:37:40

A Novel Treatment Option for Hepatocellular Carcinoma

3/25/2018
More
In this episode of The OncoZine Brief, Peter Hofland, Ph.D and Sonia Portillo talk with Gisela Schwab, MD, President, Product Development and Medical Affairs and Chief Medical Officer at Excelixis. Following early work in model genetic systems, Exelixis, a genomics-based drug discovery company located in South San Francisco, CA, established a broad drug discovery and development platform that has served as the foundation for the company’s continued efforts to bring new cancer therapies to...

Duration:00:39:33

A Cure Within - Understanding the Power of the Immune System in the Treatment of Cancer

3/5/2018
More
In this episode of The Onco’Zine Brief Peter Hofland, Ph.D and Sonia Portillo are speaking with Joshua A. Hill, MD, an Associate in Vaccine and Infectious Disease Division at Fred Hutchinson Cancer Center in Seattle Washington. Dr. Hill is also an attending physician at the Seattle Cancer Care Alliance, as well as an Assistant Professor at the University of Washington. In today's show Hofland and Portillo ask Dr. Hill about CAR T cell therapy- a technology that holds very high expectations...

Duration:00:37:33

Pogress in the Treatment of Multiple Myeloma - An Interview with Dr. Noopur Raje

3/5/2018
More
In this edition of The OncoZine Brief, Peter Hofland, Ph.D and Sonia Portillo review some of the interesting studies presented at the 59th annual meeting of the American Society of Hematology – which took place December 9 – 12, 2017 in Atlanta, Georgia. They recap one of the most important healthcare conferences of the year, the annual meeting American Society of Hematology or ASH, one of these ‘must go to’ meetings for oncology and hematology specialists but also for oncology nurses,...

Duration:00:28:16

Phil Rowlands: A Focus on Global R & D

2/5/2018
More
In this Edition of The OncoZine Brief, brought to you from the 59th annual meeting of the American Society of Hematology held December 9-12, 2017 in Atlanta, Georgia, Peter Hofland, Ph.D and Sonia Portillo, B.Sc, the team behind the show, sat down with Phil Rowlands, Head, Oncology Therapeutic Area Unit, Takeda, in Cambridge, Massachusetts, United States. Takeda is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to...

Duration:00:43:24